🇺🇸 6-Thioguanine in United States

FDA authorised 6-Thioguanine on 18 January 1966

Marketing authorisations

FDA — authorised 18 January 1966

  • Application: NDA012429
  • Marketing authorisation holder: WAYLIS THERAP
  • Local brand name: THIOGUANINE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

6-Thioguanine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 6-Thioguanine approved in United States?

Yes. FDA authorised it on 18 January 1966; FDA has authorised it.

Who is the marketing authorisation holder for 6-Thioguanine in United States?

WAYLIS THERAP holds the US marketing authorisation.